Shandong Cancer Hospital and InstituteJinan, Shandong
Disclosure information not submitted.
3117 - Chemoradioimmunotherapy Followed by Chemoimmunotherapy is Tolerable and Feasible in Inoperable Biliary Tract Cancer: A Phase Ib Clinical Trial
Tuesday, October 1, 202412:45 PM – 2:00 PM ET
